Skip to main content

Gimoti (Metoclopramide Nasal Spray) & Tardive Dyskinesia and Adverse Central Nervous System Reactions

    Basic Details
    Status
    Ongoing
    Last Updated
    Friday, March 8, 2024
    Original Posting Date
    Health Outcome(s)
    adverse central nervous system reactions
    tardive dyskinesia
    Purpose
    Drug and Outcome Analysis
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    Yes